A new technology enables the control of specific brain circuits non-invasively with magnetic fields, according to a preclinical study from researchers at Weill Cornell Medicine, the Rockefeller University and the Icahn School of Medicine at Mount Sinai.
A multi-institutional clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators showed that a newer technique for collecting prostate biopsy samples reduced the risk of infection compared with traditional biopsy approaches.
Weill Cornell Medicine has received $4.2 million to study how the immune system in some people infected with HIV can keep the virus under control, which could lead to new therapies.
Immunocompromised people with persistent COVID infections can harbor drug-resistant variants of the virus, which have the potential to spread, researchers at Weill Cornell Medicine, the College of Veterinary Medicine and the NIH have found.
In a new book, Isabel Perera explains why after deinstitutionalization, some affluent democracies failed to provide adequate services for the severely mental ill while others expanded care.
A new consortium co-led by Weill Cornell Medicine has been awarded a five-year, $31 million grant from the NIH’s National Institute of Allergy and Infectious Diseases to accelerate the development of better treatment regimens for tuberculosis.
Cornell Human Ecology faculty members Denise Green ’07 and Laura Bellows have recently been awarded fellowships in the Bronfenbrenner Center for Translational Research (BCTR).
Scientists at Weill Cornell Medicine in Qatar have created an intricate molecular map of the human body and its complex physiological processes based on the analysis of thousands of molecules in blood, urine and saliva samples from 391 volunteers.